003017 大洋生物
已收盘 12-20 15:00:00
资讯
新帖
简况
大洋生物(003017)2024年三季报简析:净利润增27.6%,盈利能力上升
证券之星 · 10-20
大洋生物(003017)2024年三季报简析:净利润增27.6%,盈利能力上升
大洋生物(003017)9月30日股东户数1万户,较上期减少6.8%
证券之星 · 10-18
大洋生物(003017)9月30日股东户数1万户,较上期减少6.8%
大洋生物最新公告:投资3.02亿元建设年产800吨盐酸氨丙啉搬迁扩建技改项目
证券之星 · 10-18
大洋生物最新公告:投资3.02亿元建设年产800吨盐酸氨丙啉搬迁扩建技改项目
大洋生物(003017.SZ)发布前三季度业绩,净利润5127万元,同比增长27.60%
智通财经 · 10-18
大洋生物(003017.SZ)发布前三季度业绩,净利润5127万元,同比增长27.60%
大洋生物(003017.SZ)拟3.02亿元投建年产800吨盐酸氨丙啉搬迁扩建技改项目
智通财经 · 10-18
大洋生物(003017.SZ)拟3.02亿元投建年产800吨盐酸氨丙啉搬迁扩建技改项目
大洋生物(003017)9月19日主力资金净买入67.90万元
证券之星 · 09-19
大洋生物(003017)9月19日主力资金净买入67.90万元
大洋生物获得实用新型专利授权:“一种含焦油的氟化钠打浆萃取提纯装置”
证券之星 · 09-14
大洋生物获得实用新型专利授权:“一种含焦油的氟化钠打浆萃取提纯装置”
大洋生物(003017)2024年中报简析:净利润增31.77%,盈利能力上升
证券之星 · 08-28
大洋生物(003017)2024年中报简析:净利润增31.77%,盈利能力上升
图解大洋生物中报:第二季度单季净利润同比增225.49%
证券之星 · 08-27
图解大洋生物中报:第二季度单季净利润同比增225.49%
大洋生物(003017.SZ)发布上半年业绩,净利润3143.63万元,增长31.77%
智通财经 · 08-26
大洋生物(003017.SZ)发布上半年业绩,净利润3143.63万元,增长31.77%
大洋生物最新公告:拟推2024年员工持股计划
证券之星 · 07-31
大洋生物最新公告:拟推2024年员工持股计划
【大洋生物(003017.SZ)拟推2024年员工持股计划 股票规模不超194.7万股】智通财经APP讯,大洋生物(003017.
智通财经 · 07-31
【大洋生物(003017.SZ)拟推2024年员工持股计划 股票规模不超194.7万股】智通财经APP讯,大洋生物(003017.
大洋生物(003017.SZ)拟推2024年员工持股计划 股票规模不超194.7万股
智通财经 · 07-31
大洋生物(003017.SZ)拟推2024年员工持股计划 股票规模不超194.7万股
大洋生物获得实用新型专利授权:“一种对氟二氯苄水解制备对氟苯甲醛的装置”
证券之星 · 07-31
大洋生物获得实用新型专利授权:“一种对氟二氯苄水解制备对氟苯甲醛的装置”
大洋生物(003017.SZ)拟10股派4.5元 于7月11日除权除息
智通财经 · 07-03
大洋生物(003017.SZ)拟10股派4.5元 于7月11日除权除息
【大洋生物(003017.SZ)拟10股派4.5元 于7月11日除权除息】智通财经APP讯,大洋生物(003017.SZ)公告,公司拟向全体股东每10股派4.
智通财经 · 07-03
【大洋生物(003017.SZ)拟10股派4.5元 于7月11日除权除息】智通财经APP讯,大洋生物(003017.SZ)公告,公司拟向全体股东每10股派4.
大洋生物(003017)6月25日主力资金净买入151.39万元
证券之星 · 06-25
大洋生物(003017)6月25日主力资金净买入151.39万元
大洋生物:5月14日召开业绩说明会,投资者参与
证券之星 · 05-15
大洋生物:5月14日召开业绩说明会,投资者参与
图解大洋生物一季报:第一季度单季净利润同比减12.78%
证券之星 · 04-26
图解大洋生物一季报:第一季度单季净利润同比减12.78%
大洋生物(003017.SZ)发布一季度业绩 净利润1691.82万元 同比下降12.78%
智通财经 · 04-26
大洋生物(003017.SZ)发布一季度业绩 净利润1691.82万元 同比下降12.78%
加载更多
公司概况
公司名称:
浙江大洋生物科技集团股份有限公司
所属行业:
化学原料和化学制品制造业
上市日期:
2020-10-26
主营业务:
浙江大洋生物科技集团股份有限公司的主营业务是无机盐、兽用原料药等化学原料产品的生产和销售。公司的主要产品包括碳酸钾、碳酸氢钾、盐酸氨丙啉、2-氯-6-氟苯甲醛等。公司系国家级高新技术企业、浙江省专利示范企业,建有浙江省博士后工作站、两个省级企业技术中心和一个省级研究院;先后主持或参与起草国家/行业标准6项,覆盖了主生产线各主要产品;公司拥有发明专利42项,实用新型专利8项,在国内外核心学术期刊发表论文30余篇。
发行价格:
28.85
{"stockData":{"symbol":"003017","market":"SZ","secType":"STK","nameCN":"大洋生物","latestPrice":20.56,"timestamp":1734678204000,"preClose":20.15,"halted":0,"volume":1175400,"delay":0,"floatShares":67590800,"shares":84000000,"eps":0.7274,"marketStatus":"已收盘","marketStatusCode":5,"change":0.41,"latestTime":"12-20 15:00:00","open":20.14,"high":20.78,"low":20.14,"amount":24120900,"amplitude":0.0318,"askPrice":20.56,"askSize":6,"bidPrice":20.45,"bidSize":8,"shortable":0,"etf":0,"ttmEps":0.7274,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734917400000},"adr":0,"adjPreClose":20.15,"symbolType":"stock","openAndCloseTimeList":[[1734658200000,1734665400000],[1734670800000,1734678000000]],"highLimit":22.17,"lowLimit":18.13,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":84000000,"pbRate":1.65,"roa":"--","roe":"5.13%","epsLYR":0.6194,"committee":0.100437,"marketValue":1727000000,"floatMarketCap":1390000000,"peRate":28.265053,"changeRate":0.0203,"turnoverRate":0.0174,"status":0},"requestUrl":"/m/hq/s/003017","defaultTab":"news","newsList":[{"id":"2476074571","title":"大洋生物(003017)2024年三季报简析:净利润增27.6%,盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2476074571","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476074571?lang=zh_cn&edition=full","pubTime":"2024-10-20 06:02","pubTimestamp":1729375338,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期大洋生物发布2024年三季报。截至本报告期末,公司营业总收入6.72亿元,同比下降6.01%,归母净利润5126.58万元,同比上升27.6%。按单季度数据看,第三季度营业总收入2.35亿元,同比上升0.64%,第三季度归母净利润1982.95万元,同比上升21.51%。本报告期大洋生物盈利能力上升,毛利率同比增幅45.29%,净利率同比增幅77.65%。去年的净利率为5.44%,算上全部成本后,公司产品或服务的附加值一般。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102000000178.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["003017"],"gpt_icon":0},{"id":"2476366406","title":"大洋生物(003017)9月30日股东户数1万户,较上期减少6.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476366406","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476366406?lang=zh_cn&edition=full","pubTime":"2024-10-18 17:08","pubTimestamp":1729242524,"startTime":"0","endTime":"0","summary":"证券之星消息,近日大洋生物披露,截至2024年9月30日公司股东户数为9977.0户,较6月30日减少728.0户,减幅为6.8%。在化学原料行业个股中,大洋生物股东户数低于行业平均水平,截至9月30日,化学原料行业平均股东户数为4.53万户。从股价来看,2024年6月30日至2024年9月30日,大洋生物区间涨幅为17.62%,在此期间股东户数减少728.0户,减幅为6.8%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024101800027837.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["003017","BK0229"],"gpt_icon":0},{"id":"2476140536","title":"大洋生物最新公告:投资3.02亿元建设年产800吨盐酸氨丙啉搬迁扩建技改项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2476140536","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476140536?lang=zh_cn&edition=full","pubTime":"2024-10-18 17:03","pubTimestamp":1729242222,"startTime":"0","endTime":"0","summary":"大洋生物公告,公司拟以自筹资金3.02亿元投资建设年产800吨盐酸氨丙啉搬迁扩建技改项目。项目建成后,预计产生年营业收入1.68亿元,年均利润总额3689.42万元。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024101800027523.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","003017"],"gpt_icon":0},{"id":"2476472927","title":"大洋生物(003017.SZ)发布前三季度业绩,净利润5127万元,同比增长27.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476472927","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476472927?lang=zh_cn&edition=full","pubTime":"2024-10-18 16:20","pubTimestamp":1729239614,"startTime":"0","endTime":"0","summary":"智通财金APP讯,大洋生物(003017.SZ)发布2024年三季度报告,报告期内,公司实现营业收入6.72亿元,同比下降6.01%,实现归属于上市公司股东的净利润5127万元,同比增长27.60%,实现归属于上市公司股东的扣除非经常性损益的净利润4819万元,同比增长48.36%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1195880.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["003017"],"gpt_icon":0},{"id":"2476472630","title":"大洋生物(003017.SZ)拟3.02亿元投建年产800吨盐酸氨丙啉搬迁扩建技改项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2476472630","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476472630?lang=zh_cn&edition=full","pubTime":"2024-10-18 16:18","pubTimestamp":1729239489,"startTime":"0","endTime":"0","summary":"智通财金APP讯,大洋生物(003017.SZ)发布公告,公司拟以自筹资金3.02亿元人民币(币种下同)投资建设年产800吨盐酸氨丙啉搬迁扩建技改项目。该项目属于搬迁扩建项目,项目入园后可以较大改善现所在城镇的安全风险。并将有助于公司盐酸氨丙啉的业务扩张,增强和拓展公司的盈利能力,扩大对全球盐酸氨丙啉市场的影响力。该项目顺利建成投产后,公司盐酸氨丙啉产能优势和成本优势进一步提升,在这一领域的领先优势会有助于公司占据主导地位,对公司兽药的长远发展具有重要意义。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1195878.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0229","003017"],"gpt_icon":0},{"id":"2468549533","title":"大洋生物(003017)9月19日主力资金净买入67.90万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468549533","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468549533?lang=zh_cn&edition=full","pubTime":"2024-09-19 15:22","pubTimestamp":1726730561,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年9月19日收盘,大洋生物报收于15.56元,上涨4.5%,换手率1.46%,成交量9894.0手,成交额1528.58万元。9月19日的资金流向数据方面,主力资金净流入67.9万元,占总成交额4.44%,游资资金净流出57.05万元,占总成交额3.73%,散户资金净流出10.85万元,占总成交额0.71%。大洋生物主营业务:主要从事无机盐、兽用原料药等化学原料产品的生产和销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024091900017636.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","003017"],"gpt_icon":0},{"id":"2467702464","title":"大洋生物获得实用新型专利授权:“一种含焦油的氟化钠打浆萃取提纯装置”","url":"https://stock-news.laohu8.com/highlight/detail?id=2467702464","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467702464?lang=zh_cn&edition=full","pubTime":"2024-09-14 02:31","pubTimestamp":1726252266,"startTime":"0","endTime":"0","summary":"证券之星消息,根据天眼查APP数据显示大洋生物新获得一项实用新型专利授权,专利名为“一种含焦油的氟化钠打浆萃取提纯装置”,专利申请号为CN202420199180.X,授权日为2024年9月13日。今年以来大洋生物新获得专利授权11个,较去年同期增加了57.14%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024091400003106.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","003017"],"gpt_icon":0},{"id":"2462003128","title":"大洋生物(003017)2024年中报简析:净利润增31.77%,盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2462003128","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462003128?lang=zh_cn&edition=full","pubTime":"2024-08-28 06:21","pubTimestamp":1724797269,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期大洋生物发布2024年中报。截至本报告期末,公司营业总收入4.37亿元,同比下降9.23%,归母净利润3143.63万元,同比上升31.77%。按单季度数据看,第二季度营业总收入2.42亿元,同比上升5.21%,第二季度归母净利润1451.81万元,同比上升225.49%。本报告期大洋生物盈利能力上升,毛利率同比增幅14.08%,净利率同比增幅45.16%。预收款项变动幅度为342.52%,原因:报告期内预收房屋租金。其他应付款变动幅度为40.67%,原因:报告期末2023年度分红款未分配。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082800007538.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["003017"],"gpt_icon":0},{"id":"2462941147","title":"图解大洋生物中报:第二季度单季净利润同比增225.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2462941147","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462941147?lang=zh_cn&edition=full","pubTime":"2024-08-27 01:41","pubTimestamp":1724694069,"startTime":"0","endTime":"0","summary":"证券之星消息,大洋生物2024年中报显示,公司主营收入4.37亿元,同比下降9.23%;归母净利润3143.63万元,同比上升31.77%;扣非净利润2909.02万元,同比上升47.43%;其中2024年第二季度,公司单季度主营收入2.42亿元,同比上升5.21%;单季度归母净利润1451.81万元,同比上升225.49%;单季度扣非净利润1333.4万元,同比上升363.83%;负债率37.04%,投资收益-65.9万元,财务费用-96.36万元,毛利率19.02%。财报数据概要请见下图: 以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082700002152.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["003017"],"gpt_icon":0},{"id":"2462421919","title":"大洋生物(003017.SZ)发布上半年业绩,净利润3143.63万元,增长31.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2462421919","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462421919?lang=zh_cn&edition=full","pubTime":"2024-08-26 22:25","pubTimestamp":1724682331,"startTime":"0","endTime":"0","summary":"智通财经APP讯,大洋生物(003017.SZ)发布2024年半年度报告,报告期内,公司实现营业收入4.37亿元,同比下降9.23%。实现归属于上市公司股东的净利润3143.63万元,同比增长31.77%。实现归属于上市公司股东的扣除非经常性损益的净利润2909.02万元,同比增长47.43%。基本每股收益0.3857元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1171195.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["003017"],"gpt_icon":0},{"id":"2455156934","title":"大洋生物最新公告:拟推2024年员工持股计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2455156934","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455156934?lang=zh_cn&edition=full","pubTime":"2024-07-31 23:19","pubTimestamp":1722439178,"startTime":"0","endTime":"0","summary":"大洋生物公告,公司拟推2024年员工持股计划,参加本员工持股计划的员工总人数为不超过97人,本员工持股计划拟筹集资金总额不超过1512.84万元。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024073100046521.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","003017"],"gpt_icon":0},{"id":"2455813597","title":"【大洋生物(003017.SZ)拟推2024年员工持股计划 股票规模不超194.7万股】智通财经APP讯,大洋生物(003017.","url":"https://stock-news.laohu8.com/highlight/detail?id=2455813597","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455813597?lang=zh_cn&edition=full","pubTime":"2024-07-31 20:51","pubTimestamp":1722430319,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=astock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["003017","BK0229"],"gpt_icon":0},{"id":"2455135903","title":"大洋生物(003017.SZ)拟推2024年员工持股计划 股票规模不超194.7万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2455135903","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455135903?lang=zh_cn&edition=full","pubTime":"2024-07-31 20:51","pubTimestamp":1722430319,"startTime":"0","endTime":"0","summary":"智通财经APP讯,大洋生物(003017.SZ)披露2024年员工持股计划(草案),本员工持股计划参加的员工总人数为不超过97人,拟筹集资金总额不超过1512.84万元。本员工持股计划股票来源为公司回购专用账户中已回购的股份,股票规模为不超过194.70万股,受让公司标的股票价格为7.77元/股。此外,本员工持股计划的存续期为36个月,所获标的股票分两期解锁,锁定期分别为12个月、24个月,均自本员工持股计划草案经公司股东大会审议通过且公司公告最后一笔标的股票过户至本员工持股计划名下之日起计算。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1158266.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["003017","BK0229"],"gpt_icon":0},{"id":"2455961716","title":"大洋生物获得实用新型专利授权:“一种对氟二氯苄水解制备对氟苯甲醛的装置”","url":"https://stock-news.laohu8.com/highlight/detail?id=2455961716","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455961716?lang=zh_cn&edition=full","pubTime":"2024-07-31 02:31","pubTimestamp":1722364273,"startTime":"0","endTime":"0","summary":"证券之星消息,根据企查查数据显示大洋生物新获得一项实用新型专利授权,专利名为“一种对氟二氯苄水解制备对氟苯甲醛的装置”,专利申请号为CN202420083619.2,授权日为2024年7月30日。今年以来大洋生物新获得专利授权5个,较去年同期增加了25%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024073100003593.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","003017"],"gpt_icon":0},{"id":"2448103049","title":"大洋生物(003017.SZ)拟10股派4.5元 于7月11日除权除息","url":"https://stock-news.laohu8.com/highlight/detail?id=2448103049","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448103049?lang=zh_cn&edition=full","pubTime":"2024-07-03 19:03","pubTimestamp":1720004585,"startTime":"0","endTime":"0","summary":"智通财经APP讯,大洋生物(003017.SZ)公告,公司拟向全体股东每10股派4.5元人民币现金(含税)。除权除息日为:2024年7月11日。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1145201.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0229","003017"],"gpt_icon":0},{"id":"2448103027","title":"【大洋生物(003017.SZ)拟10股派4.5元 于7月11日除权除息】智通财经APP讯,大洋生物(003017.SZ)公告,公司拟向全体股东每10股派4.","url":"https://stock-news.laohu8.com/highlight/detail?id=2448103027","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448103027?lang=zh_cn&edition=full","pubTime":"2024-07-03 19:03","pubTimestamp":1720004585,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=astock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK0229","003017"],"gpt_icon":0},{"id":"2446860783","title":"大洋生物(003017)6月25日主力资金净买入151.39万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446860783","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446860783?lang=zh_cn&edition=full","pubTime":"2024-06-25 15:23","pubTimestamp":1719300223,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年6月25日收盘,大洋生物报收于15.89元,上涨2.85%,换手率1.88%,成交量1.27万手,成交额2023.78万元。6月25日的资金流向数据方面,主力资金净流入151.39万元,占总成交额7.48%,游资资金净流出87.54万元,占总成交额4.33%,散户资金净流出63.85万元,占总成交额3.16%。大洋生物主营业务:主要从事无机盐、兽用原料药等化学原料产品的生产和销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024062500023995.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","003017"],"gpt_icon":0},{"id":"2435638125","title":"大洋生物:5月14日召开业绩说明会,投资者参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2435638125","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2435638125?lang=zh_cn&edition=full","pubTime":"2024-05-15 18:28","pubTimestamp":1715768891,"startTime":"0","endTime":"0","summary":"证券之星消息,2024年5月15日大洋生物发布公告称公司于2024年5月14日召开业绩说明会。公司三氟乙酰系列产品项目土建主体工程已经结顶,目前还在楼层布局和相关设备选型采购阶段,项目将按计划推进。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051500031457.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","003017"],"gpt_icon":0},{"id":"2430092230","title":"图解大洋生物一季报:第一季度单季净利润同比减12.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430092230","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2430092230?lang=zh_cn&edition=full","pubTime":"2024-04-26 02:17","pubTimestamp":1714069055,"startTime":"0","endTime":"0","summary":"证券之星消息,大洋生物2024年一季报显示,公司主营收入1.95亿元,同比下降22.46%;归母净利润1691.82万元,同比下降12.78%;扣非净利润1575.62万元,同比下降6.53%;负债率33.31%,投资收益-85.39万元,财务费用-177.47万元,毛利率19.22%。财报数据概要请见下图: 以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042600003171.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["003017"],"gpt_icon":0},{"id":"2430801236","title":"大洋生物(003017.SZ)发布一季度业绩 净利润1691.82万元 同比下降12.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430801236","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2430801236?lang=zh_cn&edition=full","pubTime":"2024-04-26 00:06","pubTimestamp":1714061179,"startTime":"0","endTime":"0","summary":"智通财经APP讯,大洋生物(003017.SZ)披露2024年第一季度报告,该公司报告期实现营业收入1.95亿元,同比下降22.46%。归属于上市公司股东的净利润1691.82万元,同比下降12.78%。归属于上市公司股东的扣除非经常性损益的净利润1575.62万元,同比下降6.53%。基本每股收益为0.21元/股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1111013.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["003017"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2020-10-26","address":"浙江省杭州市建德市大洋镇朝阳路22号","stockEarnings":[{"period":"1week","weight":-0.0569},{"period":"1month","weight":0.0426},{"period":"3month","weight":0.3403},{"period":"6month","weight":0.3088},{"period":"1year","weight":-0.1213},{"period":"ytd","weight":-0.1293}],"companyName":"浙江大洋生物科技集团股份有限公司","boardCode":"AI0026","perCapita":"6774股","boardName":"化学原料和化学制品制造业","registeredCapital":"8400万元","compareEarnings":[{"period":"1week","weight":-0.007},{"period":"1month","weight":0},{"period":"3month","weight":0.2307},{"period":"6month","weight":0.1234},{"period":"1year","weight":0.154},{"period":"ytd","weight":0.1321}],"survey":" 浙江大洋生物科技集团股份有限公司的主营业务是无机盐、兽用原料药等化学原料产品的生产和销售。公司的主要产品包括碳酸钾、碳酸氢钾、盐酸氨丙啉、2-氯-6-氟苯甲醛等。公司系国家级高新技术企业、浙江省专利示范企业,建有浙江省博士后工作站、两个省级企业技术中心和一个省级研究院;先后主持或参与起草国家/行业标准6项,覆盖了主生产线各主要产品;公司拥有发明专利42项,实用新型专利8项,在国内外核心学术期刊发表论文30余篇。","serverTime":1734718344767,"listedPrice":28.85,"stockholders":"9977人(较上一季度减少95.11%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"大洋生物(003017)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供大洋生物(003017)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"大洋生物,003017,大洋生物股票,大洋生物股票老虎,大洋生物股票老虎国际,大洋生物行情,大洋生物股票行情,大洋生物股价,大洋生物股市,大洋生物股票价格,大洋生物股票交易,大洋生物股票购买,大洋生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"大洋生物(003017)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供大洋生物(003017)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}